ArticleNeoplasia (New York, N.Y.)2010

Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma.

William D Tap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.